Lam Research (NASDAQ:LRCX) Price Target Raised to $290.00

Lam Research (NASDAQ:LRCX) had its price objective lifted by TD Cowen from $170.00 to $290.00 in a research report report published on Thursday morning, MarketBeat reports. The firm currently has a buy rating on the semiconductor company’s stock.

A number of other research analysts also recently issued reports on LRCX. Berenberg Bank raised their price target on Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Stifel Nicolaus raised their price target on Lam Research from $160.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. HSBC increased their target price on Lam Research from $127.00 to $181.00 and gave the stock a “hold” rating in a research report on Friday, January 9th. Oppenheimer reaffirmed an “outperform” rating and issued a $265.00 price objective on shares of Lam Research in a research note on Thursday. Finally, Morgan Stanley set a $211.00 price objective on shares of Lam Research in a research report on Thursday, January 15th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $238.32.

Lam Research Stock Performance

NASDAQ:LRCX opened at $233.46 on Thursday. The company’s 50-day moving average is $187.29 and its two-hundred day moving average is $146.33. Lam Research has a 1-year low of $56.32 and a 1-year high of $251.87. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.60. The firm has a market capitalization of $293.23 billion, a price-to-earnings ratio of 47.84, a PEG ratio of 3.05 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter last year, the company posted $0.91 EPS. The firm’s quarterly revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts forecast that Lam Research will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were issued a dividend of $0.26 per share. The ex-dividend date was Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research’s payout ratio is currently 21.31%.

Insider Transactions at Lam Research

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 41,408 shares of company stock worth $6,248,501 in the last 90 days. Corporate insiders own 0.31% of the company’s stock.

Hedge Funds Weigh In On Lam Research

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC acquired a new position in shares of Lam Research during the fourth quarter worth approximately $25,000. IMG Wealth Management Inc. acquired a new position in Lam Research during the 2nd quarter worth approximately $26,000. Stance Capital LLC bought a new position in Lam Research in the third quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new position in Lam Research during the second quarter worth about $27,000. Finally, Triumph Capital Management bought a new stake in shares of Lam Research during the 3rd quarter worth about $27,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple major brokers sharply raised targets (many to $275–$300), signaling broad analyst bullishness after the quarter and suggesting upside versus earlier prices. These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results
• Positive Sentiment: JPMorgan and Citigroup raised targets to $300 (overweight/buy), and firms including Needham, TD Cowen, Wells Fargo, Deutsche and Stifel also lifted targets — a strong institutional vote of confidence for continued AI/foundry-driven demand. Analyst target increases (Benzinga)
• Positive Sentiment: Lam beat Q2 estimates (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B) and issued Q3 EPS guidance of $1.25–$1.45 and revenue above consensus — concrete operational drivers behind analyst upgrades. Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
• Neutral Sentiment: New Street Research raised its target to $235 but kept a neutral rating, reflecting near-term upside limited relative to recent price strength. New Street adjusts price target on Lam Research to $235
• Negative Sentiment: HSBC raised its target to $221 but maintained a “hold,” which implies downside from recent levels and highlights some analyst caution despite better results. HSBC adjusts price target on Lam Research to $221
• Negative Sentiment: Coverage notes flag valuation concerns after a large run (high P/E and steep analyst target dispersion), which may limit further upside and explains some profit‑taking. Lam Research Earnings Beat Highlights AI Demand But Raises Valuation Questions

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.